US President Joe Biden has officially signed legislation to advance medicinal cannabis research, the first time a standalone cannabis measure has passed at a federal level.

The Medical Marijuana and Cannabidiol Research Expansion Act was voted through unanimously by the Senate last month after being passed by the House of Representatives in the US summer. 

The bill eases federal restrictions on scientific research into cannabis, which is still classified as a Schedule 1 controlled substance. 

It streamlines and speeds up the application process for the approval of cannabis-related studies by the Attorney General’s office and makes it easier for scientists to request large amounts of the substance for their research.

It also encourages the US Food and Drug Administration to support the development of cannabis-derived medicines.

Reacting to the news, California Senator Dianne Feinstein (Democrat) said: “After years of negotiation, we’re finally enacting this bill that will result in critical research that could help millions.”

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Leave a comment